· Filed In: Healthcare News
The University of Michigan (UM) has been granted $58 million to fund research in advancing clinical and translational research with the help of its surrounding community. Being the largest single federal research grant in the Medical School’s history, this will help turn UM’s researchers’ best ideas and discoveries into tests, treatments, and cures.
The grant comes from the National Institutes of Health’s(NIH) National Center for Advancing Translational Sciences (NCATS) through its Clinical and Translational Science Awards (CTSA) Program. It provides up to five years of funding for the Michigan Institute for Clinical & Health Research (MICHR) and is contingent on the availability of future congressional appropriations.
The director of the MICHR, George Mashour, acknowledged that the potential cuts to the NIH proposed by President Donald Trump does create some uncertainty about the grant’s funding in the long-term. However, he remains very optimistic about this grant stating, “We don’t know what the future holds, but we’re very enthusiastic about the grant.” This will also be an opportunity to strengthen the university’s infrastructure by allowing the MICHR to partner with the UM Medical School’s Office of Research and the UM Office of Research.
They plan on involving the community with this research by having volunteers sign up for the participation in studies. Vicki Ellingrod, Pharm.D., associate director of MICHR and leader of its education team, said they “will now be able to work more directly with patients, research participants, and groups within the community, and learn how to guide research in collaboration with…[their]… MICHR scholars.” An astounding 28,000 Michiganders have signed up for UM’s MICHR volunteer registry within one day of the grant’s announcement.
For additional information, access the following resources:
Photo: Test Tubes. Digital Image. Gizmodo. 15 Jan. 2016. Web. 31 May 2017. <gizmodo.com.au>.